Jane Street’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,651
| Closed | -$251K | – | 10964 |
|
|
2022
Q2 | $251K | Sell |
7,651
-74
| -1% | -$2.34K | ﹤0.01% | 7875 |
|
|
2022
Q1 | $203K | Buy |
+7,725
| New | +$189K | ﹤0.01% | 9018 |
|
|
2021
Q3 | – | Sell |
-12,272
| Closed | -$319K | – | 11123 |
|
|
2021
Q2 | $319K | Sell |
12,272
-18,490
| -60% | -$503K | ﹤0.01% | 8040 |
|
|
2021
Q1 | $788K | Buy |
+30,762
| New | +$789K | ﹤0.01% | 5926 |
|
|
2017
Q1 | – | Sell |
-22,647
| Closed | -$788K | – | 4852 |
|
|
2016
Q4 | $788K | Buy |
22,647
+14,852
| +191% | +$583K | ﹤0.01% | 2349 |
|
|
2016
Q3 | $306K | Buy |
+7,795
| New | +$311K | ﹤0.01% | 3295 |
|
|
2016
Q2 | – | Sell |
-5,385
| Closed | -$207K | – | 4757 |
|
|
2016
Q1 | $207K | Sell |
5,385
-205
| -4% | -$7.63K | ﹤0.01% | 3670 |
|
|
2015
Q4 | $269K | Buy |
+5,590
| New | +$259K | ﹤0.01% | 3234 |
|
|
2014
Q4 | – | Sell |
-8,656
| Closed | -$255K | – | 3186 |
|
|
2014
Q3 | $255K | Buy |
+8,656
| New | +$239K | ﹤0.01% | 2013 |
|
Other funds holding NTUS
Jane Street's NTUS Position: Q3 2022 in Review
Jane Street sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 7,651 shares — an estimated $251K sold.
Jane Street first reported a position in NTUS in Q3 2014 and held it in 9 quarters. The position peaked at $788K in Q1 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Jane Street reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Jane Street sold 7,651 Natus Medical Inc shares in Q3 2022, an estimated $251K.
- Jane Street first reported a position in Natus Medical Inc in Q3 2014 and held it in 9 quarters.
- Jane Street's Natus Medical Inc position peaked at $788K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.